Back
Nuveen S&P 500 Buy-Write Income Fund Vs. Aligos Therapeutics Industry Stock Comparison
Buy
53
BXMX
Nuveen S&P 500 Buy-Write Income Fund
Last Price:
14.28
Seasonality Move:
-0.01%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Buy
53
Nuveen S&P 500 Buy-Write Income Fund (BXMX)
is a Buy
Is Nuveen S&P 500 Buy-Write Income Fund a Buy, Sell or Hold?
- The current Nuveen S&P 500 Buy-Write Income Fund [BXMX] share price is $14.25. The Score for BXMX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- BXMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BXMX Stock Price Chart
What is Nuveen S&P 500 Buy-Write Income Fund's stock price today?
-
The Nuveen S&P 500 Buy-Write Income Fund share price today is $14.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BXMX is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
BXMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 69.48 | Buy |
| Chaikin Money Flow: | -11005 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.84 - 14.12) | Buy |
| Bollinger Bands (100): | (13.24 - 13.92) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.71 | Buy |
| Relative Strength Index (14 RSI): | 85.17 | Buy |
| Chaikin Money Flow: | 491004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.08 - 27.66) | Buy |
| Bollinger Bands (100): | (7.67 - 19.61) | Buy |
BXMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.16 | Buy |
| 20-day SMA: | 14.01 | Buy |
| 50-day SMA: | 13.85 | Buy |
| 200-day SMA: | 13.38 | Buy |
| 8-day EMA: | 14.15 | Buy |
| 20-day EMA: | 14.04 | Buy |
| 50-day EMA: | 13.86 | Buy |
| 200-day EMA: | 13.46 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.48 | Buy |
| 20-day SMA: | 23.64 | Buy |
| 50-day SMA: | 14.76 | Buy |
| 200-day SMA: | 15.86 | Buy |
| 8-day EMA: | 28.77 | Buy |
| 20-day EMA: | 23.99 | Buy |
| 50-day EMA: | 18.16 | Buy |
| 200-day EMA: | 16.13 | Buy |
Nuveen S&P 500 Buy-Write Income Fund Earnings Growth & BXMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Nuveen S&P 500 Buy-Write Income Fund Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||